Donor Fecal Microbiota Transplantation Alters Gut Microbiota and Metabolites in Obese Individuals With Steatohepatitis

Donor Fecal Microbiota Transplantation Alters Gut Microbiota and Metabolites in Obese Individuals With Steatohepatitis

The intestinal microbiota has been linked to the development and prevalence of steatohepatitis in humans. Interestingly, steatohepatitis is significantly lower in individuals taking a plant‐based, low‐animal‐protein diet, which is thought to be mediated by gut microbiota. However, data on causality...

Full description

Bibliographic Details
Main Authors:	Julia J. Witjes, Loek P. Smits, Ceyda T. Pekmez, Andrei Prodan, Abraham S. Meijnikman, Marian A. Troelstra, Kristien E.C. Bouter, Hilde Herrema, Evgeni Levin, Adriaan G. Holleboom, Maaike Winkelmeijer, Ulrich H. Beuers, Krijn vanLienden, Judith Aron‐Wisnewky, Ville Mannisto, Jacques J. Bergman, Jurgen H. Runge, Aart J. Nederveen, Lars O. Dragsted, Prokopis Konstanti, Erwin G. Zoetendal, Willem deVos, Joanne Verheij, Albert K. Groen, Max Nieuwdorp
Format:	Article
Language:	English
Published:	Wolters Kluwer Health/LWW 2020-11-01
Series:	Hepatology Communications
Online Access:	https://doi.org/10.1002/hep4.1601

Similar Items

Fecal microbiota transplantation beyond Clostridioides difficile infections
by: Koen Wortelboer, et al.
Published: (2019-06-01)

Targeting nonalcoholic fatty liver disease via gut microbiome-centered therapies
by: Mijra Koning, et al.
Published: (2023-12-01)

Faecal Microbiota transplantation affects liver DNA methylation in Non-alcoholic fatty liver disease: a multi-omics approach
by: Daniela Stols-Gonçalves, et al.
Published: (2023-12-01)

From fecal microbiota transplantation toward next-generation beneficial microbes: The case of Anaerobutyricum soehngenii
by: Koen Wortelboer, et al.
Published: (2022-12-01)

A natural history study of paediatric non-alcoholic fatty liver disease over 10 years
by: Laura Draijer, et al.
Published: (2023-05-01)

Effect of Fecal Microbiota Transplantation Combined With Mediterranean Diet on Insulin Sensitivity in Subjects With Metabolic Syndrome
by: Annefleur M. Koopen, et al.
Published: (2021-06-01)

Self-supervised neural network improves tri-exponential intravoxel incoherent motion model fitting compared to least-squares fitting in non-alcoholic fatty liver disease
by: Marian A. Troelstra, et al.
Published: (2022-09-01)

No interplay between gut microbiota composition and the lipopolysaccharide‐induced innate immune response in humans in vivo
by: Quirine LM Habes, et al.
Published: (2021-01-01)

Investigating the Gut Microbiota Composition of Individuals with Attention-Deficit/Hyperactivity Disorder and Association with Symptoms
by: Joanna Szopinska-Tokov, et al.
Published: (2020-03-01)

Gut Microbiota as a Trigger for Metabolic Inflammation in Obesity and Type 2 Diabetes
by: Torsten P. M. Scheithauer, et al.
Published: (2020-10-01)

Evaluating causality of cellular senescence in non-alcoholic fatty liver diseaseKey points
by: Abraham Stijn Meijnikman, et al.
Published: (2021-08-01)

Challenges and costs of donor screening for fecal microbiota transplantations
by: Mèlanie V. Bénard, et al.
Published: (2022-01-01)

Challenges and costs of donor screening for fecal microbiota transplantations.
by: Mèlanie V Bénard, et al.
Published: (2022-01-01)

Differences in Microbiota Membership along the Gastrointestinal Tract of Piglets and Their Differential Alterations Following an Early-Life Antibiotic Intervention
by: Chunlong Mu, et al.
Published: (2017-05-01)

Effect of Vegan Fecal Microbiota Transplantation on Carnitine‐ and Choline‐Derived Trimethylamine‐N‐Oxide Production and Vascular Inflammation in Patients With Metabolic Syndrome
by: Loek P. Smits, et al.
Published: (2018-04-01)

Fecal microbiota transplantation and fiber supplementation, better together?
by: Nordin M.J. Hanssen, et al.
Published: (2021-09-01)

Randomised double-blind placebo-controlled trial protocol to evaluate the therapeutic efficacy of lyophilised faecal microbiota capsules amended with next-generation beneficial bacteria in individuals with metabolic dysfunction-associated steatohepatitis
by: Joanne Verheij, et al.
Published: (2025-01-01)

Faecal microbiota composition and impulsivity in a cohort of older adults with metabolic syndrome
by: Prokopis Konstanti, et al.
Published: (2024-11-01)

An evaluation of the therapeutic potential of fecal microbiota transplantation to treat infectious and metabolic diseases
by: Albert K Groen, et al.
Published: (2016-11-01)

Dietary carbohydrate source influences molecular fingerprints of the rat faecal microbiota
by: Dragsted Lars O, et al.
Published: (2006-11-01)

Correction: Szopinska-Tokov et al. Investigating the Gut Microbiota Composition of Individuals with Attention-Deficit/Hyperactivity Disorder and Association with Symptoms. <i>Microorganisms</i> 2020, <i>8</i>, 406
by: Joanna Szopinska-Tokov, et al.
Published: (2021-06-01)

Immunomodulatory properties of Streptococcus and Veillonella isolates from the human small intestine microbiota.
by: Bartholomeus van den Bogert, et al.
Published: (2014-01-01)

Carbohydrate quality, fecal microbiota and cardiometabolic health in older adults: a cohort study
by: Alessandro Atzeni, et al.
Published: (2023-12-01)

The Role of Gut Microbiota and Its Produced Metabolites in Obesity, Dyslipidemia, Adipocyte Dysfunction, and Its Interventions
by: Max S. Z. Zwartjes, et al.
Published: (2021-08-01)

Gut Microbiota in Nutrition and Health with a Special Focus on Specific Bacterial Clusters
by: Lucas R. F. Bresser, et al.
Published: (2022-09-01)

Dietary Interventions in Patients With Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
by: Veera Houttu, et al.
Published: (2021-07-01)

The gut microbiota and depressive symptoms across ethnic groups
by: Jos A. Bosch, et al.
Published: (2022-12-01)

Intrapancreatic fat deposition is unrelated to liver steatosis in metabolic dysfunction-associated steatotic liver disease
by: Anne Linde Mak, et al.
Published: (2024-03-01)

Causality of small and large intestinal microbiota in weight regulation and insulin resistance
by: Torsten P.M. Scheithauer, et al.
Published: (2016-09-01)

Short-Term Microbiota Manipulation and Forearm Substrate Metabolism in Obese Men: A Randomized, Double-Blind, Placebo-Controlled Trial
by: Dorien Reijnders, et al.
Published: (2018-08-01)

Salivary microbiota reflecting changes in subgingival microbiota
by: Jae-Suk Jung, et al.
Published: (2024-11-01)

Biliary Microbiota in Choledocholithiasis and Correlation With Duodenal Microbiota
by: Jinyan Han, et al.
Published: (2021-04-01)

Associations of the oral microbiota and Candida with taste, smell, appetite and undernutrition in older adults
by: Kristina S. Fluitman, et al.
Published: (2021-12-01)

An in vitro fermentation model to study the impact of bacteriophages targeting Shiga toxin-encoding Escherichia coli on the colonic microbiota
by: Graça Pinto, et al.
Published: (2022-09-01)

Anaerobic Feces Processing for Fecal Microbiota Transplantation Improves Viability of Obligate Anaerobes
by: Mèlanie V. Bénard, et al.
Published: (2023-09-01)

DE VOORTGEZETTE EDUCATIE VAN REGISTERACCOUNTANTS
by: H. Winkelmeijer
Published: (1978-07-01)

Does aerobic exercise reduce NASH and liver fibrosis in patients with non-alcoholic fatty liver disease? A systematic literature review and meta-analysis
by: Veera Houttu, et al.
Published: (2022-11-01)

The interaction between oral microbiota and gut microbiota in atherosclerosis
by: Xinsi Li, et al.
Published: (2024-06-01)

Gut microbiota and microbiota-derived metabolites in cardiovascular diseases
by: Xiaofeng Chen, et al.
Published: (2023-10-01)

Fecal Microbiota Transplantation and the Brain Microbiota in Neurological Diseases
by: Marco Ruggiero
Published: (2016-11-01)